Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Alison Massed

Registered Nurse Boston, MA Nurse Practitioner

NPI 1033773908 CMS profile 11227840

860 Washington St, Boston, MA 02111

Open in the dashboard

General payments

$1,390

62 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alison Massed of Boston, MA is reported in the CMS Open Payments database as having received $1,390 across 62 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Registered Nurse profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $214 3
2024 General $160 2
2023 General $142 19
2022 General $522 26
2021 General $352 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alison Massed
  • Registered Nurse median
  • Middle half of Registered Nurse
  • National median

In program year 2025, general payments to Alison Massed were reported at $214. Among 1,661 Registered Nurse profiles paid that year, the median was $74 and the middle half received between $27 and $193.

Show as a table
Year Alison Massed Registered Nurse median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $352 $53 $20–$148 $132
2022 $522 $53 $21–$146 $149
2023 $142 $84 $26–$196 $160
2024 $160 $80 $26–$187 $164
2025 $214 $74 $27–$193 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $1,016 57 payments
  2. Abiomed $160 2 payments
  3. Boston Scientific Corporation $133 1 payment
  4. Edwards Lifesciences Corporation $81 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,390 62 payments
Products named General payments · program years 2021–2025
  1. COREVALVE EVOLUT R $659 44 payments
  2. CoreValve Evolut $352 12 payments
  3. Impella $160 2 payments
  4. WATCHMAN FLX $133 1 payment
  5. SAPIEN 3 Ultra RESILIA $66 1 payment
  6. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $14 1 payment
  7. NA $6 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

285

Median for Nurse Practitioner: 389

Drug cost

$22,485

Median for Nurse Practitioner: $21,885

Branded share of claims

22.5%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 16 $18,934
Atorvastatin Calcium Generic 39 $928
Metoprolol Succinate Generic 44 $700
Clopidogrel Clopidogrel Bisulfate Brand 33 $535
Torsemide Generic 12 $324
Isosorbide Mononitrate Er Isosorbide Mononitrate Brand 15 $287
Amlodipine Besylate Generic 22 $251
Furosemide Generic 42 $180
Lisinopril Generic 20 $176
Losartan Potassium Generic 11 $150

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$16,197

Medicare's payments for the services billed

Medicare patients

141

Average age 80

Services billed

226

69 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 63%
Chronic kidney disease 55%
Atrial fibrillation 49%
Arthritis 48%
Diabetes 43%
COPD 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

62 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Registered Nurse in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record